Biogen Idec names billionaire as board member
CAMBRIDGE, Mass. Biogen Idec appointed a nominee of billionaire investor Carl Icahn to its board Monday, the Swiss drug maker announced.
Biogen Idec appointed Icahn Partners nominee Eric Rowinsky and Stephen Sherwin, selected by the company as part of its effort to find new directors, to its board of directors.
On the same day, Bloomberg quoted Icahn as saying that he would like to see Biogen Idec sold to a larger drug maker, on account of its pipeline, and also split into two business units, one for neurology and one for cancer.